Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 332 followers

Latest posts

Last updated about 4 hours ago

Human medicines European public assessment report (EPAR): Lonquex, lipegfilgrastim, Date of authorisation: 25/07/2013, Revision: 29, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): Lonquex, lipegfilgrastim, Date of authorisation...

Human medicines European public assessment report (EPAR): Opzelura, ruxolitinib, Date of authorisation: 19/04/2023, Revision: 6, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): Opzelura, ruxolitinib, Date of authorisation...

Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Date of authorisation: 22/05/2014, Revision: 33, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): Entyvio, vedolizumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Palsonify, paltusotine, Date of authorisation: 23/04/2026, Revision: 1, Status: Authorised

about 4 hours ago

Human medicines European public assessment report (EPAR): Palsonify, paltusotine, Date of authorisation...

Human medicines European public assessment report (EPAR): Rimmyrah, ranibizumab, Date of authorisation: 05/01/2024, Revision: 5, Status: Authorised

about 5 hours ago

Human medicines European public assessment report (EPAR): Rimmyrah, ranibizumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Rezzayo, rezafungin, Date of authorisation: 22/12/2023, Revision: 4, Status: Authorised

about 5 hours ago

Human medicines European public assessment report (EPAR): Rezzayo, rezafungin, Date of authorisation...

Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of authorisation: 18/05/2020, Revision: 21, Status: Authorised

about 7 hours ago

Human medicines European public assessment report (EPAR): Zolgensma, onasemnogene abeparvovec, Date of...

IRIS guide for applicants - How to create, submit and manage IRIS applications, for industry and individual applicants

about 8 hours ago

IRIS guide for applicants - How to create, submit and manage IRIS...

IRIS guide to registration and RPIs

about 8 hours ago

IRIS guide to registration and RPIs

Notifying EMA of changes to contact persons (veterinary medicines)

about 8 hours ago

Notifying EMA of changes to contact persons (veterinary medicines)

Contacting EMA: post-authorisation

about 8 hours ago

Contacting EMA: post-authorisation